Immunoglobulin G - China Biologic Products

Drug Profile

Immunoglobulin G - China Biologic Products

Alternative Names: Human immunoglobulin; Human immunoglobulin 10%; Human immunoglobulin 5%; Immunoglobulin intravenous 10% - China Biologic Products; Immunoglobulin intravenous 5% - China Biologic Products; Intravenous immunoglobulin - China Biologic Products

Latest Information Update: 20 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator China Biologic Products
  • Class Immunoglobulin isotypes
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Immunodeficiency disorders

Most Recent Events

  • 25 Feb 2016 China Biologic Products receives approval for clinical trial by the CFDA (China Biologic Products, Form 10-K, February 2016)
  • 01 Jan 2014 Launched prior to 2014 for Immunodeficiency disorders in China (IV; 5% and 10%)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top